Tesamoreln Peptide, 20 mg by Verified peptides

Verified Peptides Tesamorelin Peptide 20 mg is a lyophilized synthetic growth-hormone-releasing hormone analogue supplied exclusively for controlled professional laboratory research. The product listing identifies a total quantity of 20 mg per vial and a supplier-declared purity of at least 99%, verified using high-performance liquid chromatography and mass spectrometry.

Tesamorelin is scientifically classified as an analogue of growth-hormone-releasing hormone, also described as GHRH or GHRF. This classification makes it relevant to non-clinical investigations of receptor-mediated pituitary signaling, endogenous growth-hormone secretion, downstream IGF-1 responses and related endocrine pathways.

Important classification: This research vial is not a dietary supplement, consumer wellness product or approved prescription medication. It must not be confused with branded pharmaceutical tesamorelin formulations such as EGRIFTA SV or EGRIFTA WR. Pharmaceutical formulations have specific manufacturing controls, excipients, strengths, clinical indications and prescribing information that do not apply to this 20 mg research material.

Tesamorelin in Laboratory Research

GHRH-Receptor Signaling: Tesamorelin-related research can examine signaling initiated through growth-hormone-releasing hormone receptors in suitable validated experimental systems. This may include receptor activation, pituitary-cell responses and downstream biochemical measurements.

Growth-Hormone Axis Investigations: Scientific studies involving tesamorelin have examined its relationship with pulsatile endogenous growth-hormone secretion and subsequent IGF-1 signaling. Results depend on the research model, material identity, purity, concentration, analytical method and experimental controls.

Metabolic and Body-Composition Research: Pharmaceutical tesamorelin has been clinically studied for a narrowly defined medical indication involving excess abdominal fat in adults with HIV-associated lipodystrophy. This evidence cannot be generalized into a weight-loss, bodybuilding, anti-aging or consumer-use claim for a research vial.

Experimental Interpretation: Data generated using research-grade material should not be treated as evidence of safety, efficacy, pharmaceutical equivalence or suitability for clinical use. Researchers must document the batch, certificate of analysis, preparation conditions, controls and analytical limitations.

Key Research Features

Product Specifications

Research Handling and Documentation

Receiving and Documentation

Upon receipt, qualified personnel should document the product identity, batch number, stated quantity, packaging condition and storage history. Review the supplier’s certificate of analysis and confirm that the reported analytical methods and acceptance criteria are appropriate for the intended research protocol.

Laboratory Storage

According to the product listing, store the sealed vial at 2–8°C protected from light. A temperature of −20°C is stated for extended storage. Researchers should also follow batch-specific supplier documentation and institutional stability requirements.

Controlled Handling

Handle only in a qualified laboratory using suitable personal protective equipment, calibrated instruments, appropriate containment and an approved chemical-hygiene or biosafety protocol. Avoid inhalation, ingestion, skin exposure and cross-contamination.

Preparation and Experimental Use

No human dosage, reconstitution, injection, compounding or self-experimentation instructions are provided or implied. Laboratory preparation parameters must be established through verified supplier documentation, validated methods and an institutionally approved research protocol.

Disposal

Unused material, contaminated consumables and experimental waste should be disposed of according to institutional procedures and applicable chemical or biological waste regulations. Do not discard research material through household waste or drains.

Frequently Asked Questions

What is Tesamorelin?

Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone. It is scientifically relevant to investigations of GHRH-receptor activation, pituitary signaling, endogenous growth-hormone release and downstream IGF-1 responses.

Does this vial contain 20 mg per dose?

No dosage is established or implied. The 20 mg value is the stated total amount of research material in the vial, not a human or veterinary dose.

Is this product FDA-approved EGRIFTA?

No. It is a research-use-only product from Verified Peptides and must not be represented as EGRIFTA, a generic equivalent or an FDA-approved pharmaceutical formulation.

Is pharmaceutical Tesamorelin approved for general weight loss?

No. FDA-approved pharmaceutical tesamorelin has a specific indication involving excess abdominal fat in adults with HIV-associated lipodystrophy. FDA labeling states that it is not indicated for general weight-loss management.

Can this research vial be injected or consumed?

No. The product listing expressly states that it is not intended for human or veterinary consumption or administration.

Does ≥99% purity prove pharmaceutical quality?

No. Analytical purity is only one quality attribute. It does not establish sterility, endotoxin limits, pharmaceutical manufacturing compliance, clinical safety, dosing accuracy or equivalence to an approved medicine.

What do HPLC and mass spectrometry verify?

HPLC can assess chromatographic purity, while mass spectrometry can support molecular-identity assessment. Researchers should review the actual certificate, chromatograms, spectra, test date and batch identifiers rather than relying only on a summary claim.

Is Tesamorelin prohibited in competitive sport?

Yes. The World Anti-Doping Agency lists GHRH and its analogues, including Tesamorelin, among substances prohibited at all times. Athletes and support personnel should consult the current WADA list and their governing body.

Research-use notice: For controlled laboratory research only. Not a dietary supplement, medicine or cosmetic product. Not intended for human or veterinary consumption, administration, diagnosis, treatment, cure or disease prevention.